Researchers found “no significant discrepancy in safety events” between trastuzumab biosimilars and the originator product.

Patients with EGFR-mutant, oligometastatic NSCLC who received radiotherapy plus icotinib had longer overall and progression-free survival than those who received icotinib alone.

Democrats and Republicans in statehouses around the country have been working together to tackle the nation’s medical debt crisis.

Hospitals have been bracing for a nationwide shortage of IV fluids after Hurricane Helene knocked out a North Carolina production plant, but a plant in Daytona Beach, Florida, was spared by Hurricane ...

More than half of US physician peer reviewers for the most influential medical journals receive industry payments, according to research.

The FDA has approved Itovebi in combination with palbociclib and fulvestrant to treat certain patients with PIK3CA-mutant breast cancer.

The United States launched the most new cancer drugs during the study period (n=345). Other countries with a high number of launches were Japan (n=224), Canada (n=221), Australia (n=204), the United ...

Half of patients surveyed said they would be less likely to open a patient portal account if they thought their parents would be able to access their medical information.

Artificial intelligence may be able to estimate the risk of future breast cancer and lead to earlier diagnosis, a new study suggests.

(HealthDay News) — Overall survival (OS) after umbilical cord blood transplant (UCBT) has improved over time, according to a study published in Transplantation and Cellular Therapy.

Researchers characterized the prevalence of and risk factors for clinically significant fear of cancer recurrence in 220 adult survivors of childhood cancer. They were treated at 31 institutions ...

The Florida DOH is trying to stop a TV station from airing an ad featuring a pregnant woman who was diagnosed with stage IV brain cancer.